logo-loader

Iovance Biotherapeutics

Market:
NASDAQ
Market Cap:
$3.01 billion
Price
23.83 USD
Change
0.51%
52 weeks high
29.64
52 weeks low
9.22

In brief

IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL).